Printer Friendly

Novozymes A/S reports operating profit of DKK1,090m.

NORDIC BUSINESS REPORT-31 January 2005-Novozymes A/S reports operating profit of DKK1,090m(C)1994-2005 M2 COMMUNICATIONS LTD

The Danish biotech company Novozymes A/S issued its year-end statement on Monday (31 January), posting an operating profit of DKK1,090m, as compared to DKK982m in 2003.

Sales amounted to DKK6,024m, as compared to DKK5,803m in 2003. Calculated in local currencies sales rose by 8%.

Novozymes said that it expected the development to continue along the same lines in 2005: "Sales in local currencies are expected to increase by 6-7%. Calculated in DKK, sales are expected to rise by around 4%. Growth in operating profit calculated in local currencies is expected to exceed 10%. Calculated in DKK, operating profit is expected to rise by just below 6%."

One Danish krone (DKK) is worth approximately 0.09 British pounds (GBP).

((Comments on this story may be sent to

COPYRIGHT 2005 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Nordic Business Report
Article Type:Brief Article
Geographic Code:4EUDE
Date:Jan 31, 2005
Previous Article:Lundin Petroleum AB awarded frontier exploration licence offshore Ireland.
Next Article:El & Industrimontage Holding i Norrland AB wins power contract from LKAB.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters